Pharma Focus Europe

Projects

The pharmaceutical projects listed in this section are those that are announced from time to time around the world

PCI's New Facility Expansion Begins with Installation of Sterile Fill-Finish and Lyophilization Line in $100 Million Capital Investment

The leading CDMO is currently installing key equipment for its latest sterile fillfinish facility, including twin lyophilizers and a stateoftheart largescale isolator filling line

Merck Invests Over €300M in Advanced Life Science Research Center in Germany

Merck is investing over 300 million in a new research center at its global headquarters in Darmstadt, Germany This Advanced Research Center will focus on developing solutions

£400 Million Investment by Almac Group to Boost Manufacturing and Peptide Production

The Almac Group has introduced two stateoftheart facilities at its Craigavon headquarters in Northern Ireland, pushing its global expansion investment to over 400 million $500 million

Novartis Invests $256 Million to Expand Singapore Biopharma Plant

In a significant move to enhance its global production capabilities, Novartis has announced a commitment of $256 million to expand its biopharma plant in Singapore

Pharmascience Expands CDMO Services with $120M Commercial Unit Investment in Canada

Pharmascience, Canadas leading pharmaceutical company, announces an expansion of its sterile injectable manufacturing facility at the Candiac site

Simtra BioPharma Invests $250 Million in Bloomington Sterile Fill/Finish Site

Simtra BioPharma Solutions, recently acquired by Advent International and Warburg Pincus, is expanding its sterile fillfinish manufacturing campus in Bloomington, Indiana

The Ground breaking Commencement of Lek's $400M Biopharmaceutical Production Center Project in Lendava

Initiation of construction for Leks advanced biopharmaceutical production center in Lendava is underway The construction will occur on Leks existing site in Lendava and involves three planned facilities

BioNTech's $150M Investment Propels Rwanda toward mRNA Vaccine Manufacturing Hub

BioNTech SE reaches a significant milestone with the inauguration of its mRNA vaccine manufacturing site in Kigali, Rwanda The site includes the establishment of the first manufacturing

Novo Nordisk Initiates Groundbreaking 16 Billion Danish Kroner Investment for State-of-the-Art Expansion in France

The expansion is geared towards enhancing production capabilities for the current and future portfolio focused on serious chronic diseases

Novo Nordisk Invests Over 42 Billion Danish Kroner in Expanding Manufacturing Facilities in Kalundborg

Novo Nordisk plans to invest more than 42 billion Danish kroner starting in 2023 The investment is focused on expanding existing manufacturing facilities in Kalundborg, Denmark

magazine-slider-img
Thermo Fisher Scientific - mRNA ServicesWorld Orphan Drug Congress 2024World Vaccine Congress Europe 2024Advanced Therapies USA 2024
cytiva